Celldex Therapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $595k | 15k | 39.68 |
| 2023-09-30 | $211k | 7.8k | 27.14 |
| 2023-06-30 | $170k | 5.0k | 33.87 |
| 2022-12-31 | $226k | 5.4k | 41.92 |
| 2022-09-30 | $17k | 593 | 29.41 |
| 2021-06-30 | $90k | 2.7k | 33.53 |
| 2020-12-31 | $4.0k | 245 | 16.33 |
| 2020-09-30 | $0 | 13 | 0.00 |
| 2020-06-30 | $3.2k | 272 | 11.58 |
| 2020-03-31 | $2.0k | 1.4k | 1.41 |
| 2019-12-31 | $1.0k | 485 | 2.12 |
| 2019-09-30 | $1.0k | 569 | 1.80 |
| 2019-03-31 | $0 | 13 | 0.00 |